Identification and characterization of opioid growth factor receptor in human pancreatic adenocarcinoma.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  International Journal of Molecular Medicine

• Publication date

  2000-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0016-5085(00)80450-3PMID 10601579
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics

  1999cited by this paper
• Cancer statistics, 1999

  1999cited by this paper
• Opioid growth factor and organ development in rat and human embryos.

  1999cited by this paper
• Human neuroblastoma cell growth in tissue culture is regulated by opioid growth factor.

  1999cited by this paper
• Growth Factors and Cytokines in Pancreatic Carcinogenesis

  1999cited by this paper
• Regulation of human head and neck squamous cell carcinoma growth in tissue culture by opioid growth factor.

  1999cited by this paper
• Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor.

  1999cited by this paper
• The molecular and cellular biology of pancreatic cancer.

  1998cited by this paper
• Expression of transforming growth factor beta1 (TGFbeta1) and its receptors in pancreatic duct cell carcinoma and in chronic pancreatitis.

  1998cited by this paper
• NEUROTROPHIN‐3 EXPRESSION IN HUMAN PANCREATIC CANCERS

  1997cited by this paper
• Opioid growth factor (OGF) inhibits human pancreatic cancer transplanted into nude mice.

  1997cited by this paper
• Molecular advances in pancreatic cancer.

  1997cited by this paper
• Homeostasis of ocular surface epithelium in the rat is regulated by opioid growth factor.

  1997cited by this paper
• Enkephalins modulate differentiation of normal human keratinocytes in vitro

  1997cited by this paper
• Regulation of DNA synthesis of myocardial and epicardial cells in developing rat heart by [Met5]enkephalin.

  1996cited by this paper
• Suppressive effect of met-enkephalin on bone marrow cell proliferation in vitro shows circadian pattern and depends on the presence of adherent accessory cells.

  1996cited by this paper
• Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture.

  1996cited by this paper
• Opioids regulate cell proliferation in the developing rat uterus: effects during the period of sexual maturation.

  1996cited by this paper
• Identification and characterization of zeta-opioid receptor in human colon cancer.

  1996cited by this paper
• The opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor are present in human and mouse skin and tonically act to inhibit DNA synthesis in the epidermis.

  1996cited by this paper
• Opioid growth factor ([Met5]enkephalin) prevents the incidence and retards the growth of human colon cancer.

  1996cited by this paper
• Met-enkephalin-containing peptides encoded by proenkephalin A mRNA expressed in activated murine thymocytes inhibit thymocyte proliferation.

  1995cited by this paper
• Increased tumorigenicity in the human pancreatic cell line MIA PaCa‐2 Is associated with an aberrant regulation of an IGF‐1 autocrine loop and lack of expression of the TGF‐β type RII receptor

  1995cited by this paper
• Beta-endorphin is a potent inhibitor of thymidine incorporation into DNA via mu- and kappa-opioid receptors in fetal rat brain cell aggregates in culture.

  1993cited by this paper
• Tumor necrosis factor alpha induces the expression of transforming growth factor alpha and the epidermal growth factor receptor in human pancreatic cancer cells.

  1993cited by this paper
• Expression of prepro‐enkephalin in human articular chondrocytes is linked to cell proliferation.

  1992cited by this paper
• Differential binding and biological activities of epidermal growth factor and transforming growth factor alpha in a human pancreatic cancer cell line.

  1991cited by this paper
• Zeta (zeta), a growth-related opioid receptor in developing rat cerebellum: identification and characterization.

  1991cited by this paper
• Endogenous opioids modulate neuronal survival in the developing avian ciliary ganglion

  1991cited by this paper
• Effects of central administration of beta-endorphin on brain and liver DNA synthesis in preweanling rats.

  1991cited by this paper
• Demonstration and characterization of zeta (zeta), a growth-related opioid receptor, in a neuroblastoma cell line.

  1990cited by this paper
• The antimetastatic activity of enkephalin-like peptides.

  1987cited by this paper
• Inhibition of B16-BL6 melanoma growth in mice by methionine-enkephalin.

  1985cited by this paper
• Duration of opiate receptor blockade determines tumorigenic response in mice with neuroblastoma: a role for endogenous opioid systems in cancer.

  1984cited by this paper
• Endogenous opioids: biology and function.

  1984cited by this paper
• Increased brain size and cellular content in infant rats treated with an opiate antagonist.

  1983cited by this paper
• Naltrexone modulates tumor response in mice with neuroblastoma.

  1983cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper

• Morphine Analgesia, Cannabinoid Receptor 2, and Opioid Growth Factor Receptor Cancer Tissue Expression Improve Survival after Pancreatic Cancer Surgery

  2023cites this paper
• Ultrasound-guided paravertebral blockade reduced perioperative opioids requirement in pancreatic resection: A randomized controlled trial

  2022cites this paper
• Opioidergic Signaling—A Neglected, Yet Potentially Important Player in Atopic Dermatitis

  2022influential citation
• Epidural Analgesia after Gynecologic Oncology Surgery in the Era of Enhanced Recovery

  2018cites this paper
• Methionine enkephalin, its role in immunoregulation and cancer therapy.

  2016cites this paper
• The Various Functions of Opioids in Pathophysiological Conditions

  2015cites this paper
• Opioid growth factor and the treatment of human pancreatic cancer: a review.

  2014cites this paper
• Opioid System and Alzheimer’s Disease

  2012cites this paper
• The Profile of Plasma Met-Enkephalin Concentration in Patients with Renal Cell Carcinoma* Ocena zachowania się stężeń Met-enkefalin w osoczu krwi chorych na raka jasnokomórkowego nerki

  2011cites this paper
• Methadone induces necrotic-like cell death in SH-SY5Y cells by an impairment of mitochondrial ATP synthesis.

  2010cites this paper
• Opioid growth factor improves clinical benefit and survival in patients with advanced pancreatic cancer.

  2010cites this paper
• Endogenous opioids and multiple sclerosis

  2009cites this paper
• New insights into the role of endogenous opioids in the pathogenesis of gastrointestinal and liver disease

  2009cites this paper
• Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers.

  2009cites this paper
• The role of opioid growth factor in enhancing the success of trabeculectomy

  2009cites this paper
• The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer

  2008cites this paper
• Prevention and delay in progression of human pancreatic cancer by stable overexpression of the opioid growth factor receptor.

  2008cites this paper
• Expression of Opioid Growth Factor (OGF)–OGF Receptor (OGFr) Axis in Human Nonmedullary Thyroid Cancer

  2008cites this paper
• Overexpression of the opioid growth factor receptor potentiates growth inhibition in human pancreatic cancer cells.

  2007cites this paper
• Structure-activity relationships of alphaS1-casomorphin using AM1 calculations and molecular dynamics simulations.

  2007cites this paper
• Opioids and migration, chemotaxis, invasion, and adhesion of human cancer cells.

  2007cites this paper
• Stability of Opioid Growth Factor ([Met5]‐Enkephalin) in Solution Using HPLC and Photodiode Array Detection

  2006cites this paper
• Progression of squamous cell carcinoma of the head and neck is associated with down-regulation of the opioid growth factor receptor.

  2006cites this paper
• Opioid growth factor receptor is unaltered with the progression of human pancreatic and colon cancers.

  2006cites this paper
• Opioids and differentiation in human cancer cells.

  2005cites this paper
• Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma

  2005cites this paper
• Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cells.

  2004cites this paper
• Treatment of advanced pancreatic cancer with opioid growth factor: phase I

  2004cites this paper
• Binding of the new morphiceptin analogs to human MCF-7 breast cancer cells and their effect on growth.

  2004cites this paper
• The expression and function of the OGF-OGFr axis - a tonically active negative regulator of growth - in COS cells.

  2003cites this paper
• MUC1-like tandem repeat proteins are broadly immunogenic in cancer patients.

  2003cites this paper
• Opioid growth factor modulation of corneal epithelium: Uppers and downers

  2003cites this paper
• Diagnosing Pancreatic Cancer Using Methylation Specific PCR Analysis

  2003cites this paper
• Opioids and the apoptotic pathway in human cancer cells.

  2003cites this paper
• Opioid growth factor (OGF) inhibits the progression of human squamous cell carcinoma of the head and neck transplanted into nude mice.

  2003cites this paper
• The biology of the opioid growth factor receptor (OGFr).

  2002cites this paper
• Endogenous opiates: 2000.

  2001cites this paper
• Molecular characterization and distribution of the opioid growth factor receptor (OGFr) in mouse.

  2000cites this paper
• Opioid growth factor regulates the cell cycle of human neoplasias.

  2000cites this paper
• Treatment of advanced pancreatic cancer with opioid growth factor: Phase I

  2000cites this paper
• Elevated Levels of Opioid Growth Factor in the Plasma of Patients with Pancreatic Cancer

  2000cites this paper